Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Plunges 3%; BSE HEALTHCARE Index Down 0.6%
Wed, 10 Jul 11:29

ALKEM LABORATORIES Plunges 3%; BSE HEALTHCARE Index Down 0.6%Image source: CreativaImages/www.istockphoto.com

ALKEM LABORATORIES share price has plunged 3% and is presently trading at Rs 5,180.6.

Meanwhile, the BSE HEALTHCARE index is at 38,209.1 (down 0.6%).

Among the top losers in the BSE HEALTHCARE index today are HIKAL CHEMIC (down 2.5%) and LAURUS LABS (down 2.3%).

Pfizer (up 4.4%) and KIMS (up 2.2%) are among the top gainers today.

Over the last one year, ALKEM LABORATORIES has moved up from Rs 3,483.9 to Rs 5,180.6, registering a gain of Rs 1,696.7 (up 48.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,209.1, registering a gain of 47.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.1%), Lupin (up 99.8%) and Cadila Healthcare (up 98.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,623.5 (down 0.9%).

The top losers among the BSE Sensex today are M&M (down 6.6%) and HCl Tech. (down 2.6%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,217.1 (down 0.9%). M&M and HCl Tech. are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,623.5, registering a gain of 14,279.3 points (up 21.9%).

ALKEM LABORATORIES Financial Update...

ALKEM LABORATORIES net profit grew 349.9% YoY to Rs 3,045 million for the quarter ended March 2024, compared to a profit of Rs 677 million a year ago. Net sales rose 1.1% to Rs 29,358 million during the period as against Rs 29,026 million in January-March 2023.

For the year ended March 2023, ALKEM LABORATORIES reported 40.1% decrease in net profit to Rs 10,068 million compared to net profit of Rs 16,803 million during FY22. Revenue of the company grew 9.1% to Rs 115,993 million during FY23.

The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 34.2.


Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Plunges 3%; BSE HEALTHCARE Index Down 0.6%". Click here!